Toggle navigation
Home
About Idorsia
Idorsia today
Our strategy
Our drug discovery approach
Our pipeline
Our locations
History
Idorsia people
Our organization
Our behaviors
Leaders
Board of Directors
Target diseases
Fabry disease
Insomnia
Cerebral vasospasm
Resistant Hypertension
Lupus
Partnerships
Our responsibilities
Our Approach
Our Employees
Serving Patients
Environment
Our Communities
Governance
Internal organization of the Board
Compensation governance
Policies & Charters
Investors
Results Day Center
Our equity story
Company strategy
Development Pipeline
Corporate Governance & Sustainability
Financial information
Financial overview
Company funding
Financial archive
Corporate Reports
News & Events
Media releases
Annual General Meeting
Pipeline webcasts
Financial reporting webcasts
Stock information
Stock overview
Stock chart tool
Covering analysts
Consensus estimate
Media
Newsroom
News archive
Media center
Social media
Resources in German
Careers
Working@Idorsia
Recruitment, Development & Retention
Diversity & Inclusion
Recognition
Compensation principles
Health, Safety & Well-being
Job opportunities
Living in Basel
FAQ
Privacy policy
Contact
Newsroom
News archive
Media center
Social media
Resources in German
News details
More
novel drugs –
Inspiring
potential
Latest news
